Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Mar 19;8(3):65.
doi: 10.3390/biomedicines8030065.

Identification of Aberrantly-Expressed Long Non-Coding RNAs in Osteoblastic Cells from Osteoporotic Patients

Affiliations

Identification of Aberrantly-Expressed Long Non-Coding RNAs in Osteoblastic Cells from Osteoporotic Patients

Federica Centofanti et al. Biomedicines. .

Abstract

Osteoporosis (OP) is a multifactorial disease influenced by genetic, epigenetic, and environmental factors. One of the main causes of the bone homeostasis alteration is inflammation resulting in excessive bone resorption. Long non-coding RNAs (lncRNAs), have a crucial role in regulating many important biological processes in bone, including inflammation. We designed our study to identify lncRNAs misregulated in osteoblast primary cultures derived from OP patients (n = 4), and controls (CTRs, n = 4) with the aim of predicting possible RNA and/or protein targets implicated in this multifactorial disease. We focused on 84 lncRNAs regulating the expression of pro-inflammatory and anti-inflammatory genes and miRNAs. In silico analysis was utilized to predict the interaction of lncRNAs with miRNAs, mRNAs, and proteins targets. Six lncRNAs were significantly down-regulated in OP patients compared to controls: CEP83-AS1, RP11-84C13.1, CTC-487M23.5, GAS5, NCBP2-AS2, and SDCBP2-AS1. Bioinformatic analyses identified HDCA2, PTX3, and FGF2 proteins as downstream targets of CTC-487M23.5, GAS5, and RP11-84C13.1 lncRNAs mediated by the interaction with miRNAs implicated in OP pathogenesis, including miR-21-5p. Altogether, these data open a new regulatory mechanism of gene expression in bone homeostasis and could direct the development of future therapeutic approaches.

Keywords: bone homeostasis; epigenetics; inflammation; long non-coding RNAs; osteoblast; osteoporosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Primary human osteoblast cultures were observed under phase-contrast microscope at 10× field. Scale bar: 500 μm.
Figure 2
Figure 2
Volcano plot of LncRNAs levels in OP vs. CTRs. The Volcano plot shows the significant lncRNAs that we found down-regulated in osteoblast cell lines on the left (down-regulated) and above the solid vertical line (statistically significant), according to significant p-value and fold-regulation change. The solid vertical line represents no change in gene expression (log2 (1) = 0). The dotted lines represent a selected threshold or boundary for fold change. The default setting is 2. The solid vertical line represents a selected threshold for the p-value and statistical significance. The default setting is 0.05. Statistical significance versus fold-change is shown on the y- and x-axes, respectively [24].
Figure 3
Figure 3
Hypothetical pathogenetic mechanisms emerging from this study. (A) Growth arrest-specific 5 (GAS5) lncRNA masks miR-21-5p binding sites, (B) CTC-487M23.5 lncRNA inhibits the translation of HDAC2 mRNA, (C) NCPB2-AS2 lncRNA masks miRNA binding sites implicated in osteoblast differentiation, and (D) RP11-84C13.1 lncRNA masks miR-576-3p binding sites. ↑ and : increase; ↓: decrease; formula image: no repression; formula image: repression.

References

    1. Valdés-Flores M., Casas-Avila L., de León-Suárez V.P., Falcón-Ramírez E. Genetics and Osteoporosis. In: Dionyssiotis Y., editor. Osteoporosis. InTech; London, UK: 2012. p. 33.
    1. Mac I., Alcorta-sevillano N., Rodr C.I. Osteoporosis and the Potential of Cell-Based Therapeutic Strategies. Int. J. Mol. Sci. 2020;21:1653 - PMC - PubMed
    1. Gordon J.A.R., Montecino M.A., Aqeilan R.I., Janet L., Stein G.S., Lian J.B. Epigenetic Pathways Regulating Bone Homeostasis: Potential Targeting for Intervention of Skeletal Disorders. Curr. Osteoporos. Rep. 2014;12:496–506. doi: 10.1007/s11914-014-0240-1. - DOI - PMC - PubMed
    1. Urano T., Inoue S. Genetics of osteoporosis. Biochem. Biophys. Res. Commun. 2014;452:287–293. doi: 10.1016/j.bbrc.2014.07.141. - DOI - PubMed
    1. Richards J.B., Zheng H.-F., Spector T.D. Genetics of osteoporosis from genome-wide association studies: Advances and challenges. Nat. Rev. Genet. 2012;13:576–588. doi: 10.1038/nrg3228. - DOI - PubMed

LinkOut - more resources